Overcome costly Hit-finding challenges: Integrated platform for success

2:25 PM - 2:45 PM (PDT), Tuesday, June 14, 2022

Drug Discovery programs are empowered with a comprehensive, integrated platform offering high quality protein, in combination with other well-established capabilities including target validation, hit finding (fragment, compound or DNA Encoded Library screenings) and hit confirmation (biophysics, biochemistry). Importantly, WuXi AppTec provides our partner clients the ability to obtain structural elucidation of their target at atomic precision from X-ray crystallography, Cryo-EM or NMR.